Helen Bardwell

Fitness and transcriptional plasticity of human breast cancer single-cell-derived clones

Modeling Drug Responses and Evolutionary Dynamics Using Patient-Derived Xenografts Reveals Precision Medicine Strategies for Triple-Negative Breast Cancer

Modelling drug responses and evolutionary dynamics using triple negative breast cancer patient-derived xenografts

Multi-omic machine learning predictor of breast cancer therapy response

Imaging mass cytometry and multiplatform genomics define the phenogenomic landscape of breast cancer

Clonal replacement and heterogeneity in breast tumors treated with neoadjuvant HER2-targeted therapy

Publisher Correction: Clonal replacement and heterogeneity in breast tumors treated with neoadjuvant HER2-targeted therapy

Abstract P3-06-01: Clonal evolution and heterogeneity in breast tumors treated with neoadjuvant HER2-targeted therapy

Shallow whole genome sequencing for robust copy number profiling of formalin-fixed paraffin-embedded breast cancers

Therapeutic Rationale to Target Highly Expressed CDK7 Conferring Poor Outcomes in Triple-Negative Breast Cancer

Shallow whole genome sequencing for robust copy number profiling of formalin-fixed paraffin-embedded breast cancers

The somatic mutation profiles of 2,433 breast cancers refine their genomic and transcriptomic landscapes

Computational pathology of pre-treatment biopsies identifies lymphocyte density as a predictor of response to neoadjuvant chemotherapy in breast cancer

Abstract A30: RATHER: High-resolution molecular profiling of invasive lobular breast cancers

Quantitative Image Analysis of Cellular Heterogeneity in Breast Tumors Complements Genomic Profiling

Biological and prognostic associations of <i>miR‐205</i> and <i>let‐7b</i> in breast cancer revealed by <i>in situ</i> hybridization analysis of micro‐RNA expression in arrays of archival tumour tissue